• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p97 蛋白 D1-D2 连接区中的保守 L464 对 p97 辅助因子调节的 ATP 酶活性至关重要。

Conserved L464 in p97 D1-D2 linker is critical for p97 cofactor regulated ATPase activity.

机构信息

Division of Medical Genetics, Department of Pediatrics, Harbor-UCLA Medical Center and The Lundquist Institute, Torrance, California 90502, U.S.A.

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, U.S.A.

出版信息

Biochem J. 2021 Sep 17;478(17):3185-3204. doi: 10.1042/BCJ20210288.

DOI:10.1042/BCJ20210288
PMID:34405853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9041309/
Abstract

p97 protein is a highly conserved, abundant, functionally diverse, structurally dynamic homohexameric AAA enzyme-containing N, D1, and D2 domains. A truncated p97 protein containing the N and D1 domains and the D1-D2 linker (ND1L) exhibits 79% of wild-type (WT) ATPase activity whereas the ND1 domain alone without the linker only has 2% of WT activity. To investigate the relationship between the D1-D2 linker and the D1 domain, we produced p97 ND1L mutants and demonstrated that this 22-residue linker region is essential for D1 ATPase activity. The conserved amino acid leucine 464 (L464) is critical for regulating D1 and D2 ATPase activity by p97 cofactors p37, p47, and Npl4-Ufd1 (NU). Changing leucine to alanine, proline, or glutamate increased the maximum rate of ATP turnover (kcat) of p47-regulated ATPase activities for these mutants, but not for WT. p37 and p47 increased the kcat of the proline substituted linker, suggesting that they induced linker conformations facilitating ATP hydrolysis. NU inhibited D1 ATPase activities of WT and mutant ND1L proteins, but activated D2 ATPase activity of full-length p97. To further understand the mutant mechanism, we used single-particle cryo-EM to visualize the full-length p97L464P and revealed the conformational change of the D1-D2 linker, resulting in a movement of the helix-turn-helix motif (543-569). Taken together with the biochemical and structural results we conclude that the linker helps maintain D1 in a competent conformation and relays the communication to/from the N-domain to the D1 and D2 ATPase domains, which are ∼50 Å away.

摘要

p97 蛋白是一种高度保守、丰富、功能多样、结构动态的同六聚体 AAA 酶,包含 N、D1 和 D2 结构域。一种包含 N 和 D1 结构域以及 D1-D2 接头(ND1L)的截短 p97 蛋白表现出 79%的野生型(WT)ATP 酶活性,而单独的 D1 结构域没有接头仅有 2%的 WT 活性。为了研究 D1-D2 接头与 D1 结构域之间的关系,我们生成了 p97 ND1L 突变体,并证明这个 22 个残基的接头区域对于 D1 ATP 酶活性是必需的。保守的氨基酸亮氨酸 464(L464)对于 p97 辅助因子 p37、p47 和 Npl4-Ufd1(NU)调节 D1 和 D2 ATP 酶活性是至关重要的。将亮氨酸突变为丙氨酸、脯氨酸或谷氨酸会增加这些突变体 p47 调节的 ATP 酶活性的最大速率(kcat),但对 WT 没有影响。p37 和 p47 增加了脯氨酸取代接头的 kcat,表明它们诱导了有利于 ATP 水解的接头构象。NU 抑制 WT 和突变 ND1L 蛋白的 D1 ATP 酶活性,但激活全长 p97 的 D2 ATP 酶活性。为了进一步了解突变体机制,我们使用单颗粒冷冻电镜可视化全长 p97L464P,并揭示了 D1-D2 接头的构象变化,导致螺旋-转角-螺旋模体(543-569)的运动。综合生物化学和结构结果,我们得出结论,接头有助于将 D1 维持在有能力的构象中,并将通讯从 N 结构域传递到 D1 和 D2 ATP 酶结构域,这两个结构域之间的距离约为 50 Å。

相似文献

1
Conserved L464 in p97 D1-D2 linker is critical for p97 cofactor regulated ATPase activity.p97 蛋白 D1-D2 连接区中的保守 L464 对 p97 辅助因子调节的 ATP 酶活性至关重要。
Biochem J. 2021 Sep 17;478(17):3185-3204. doi: 10.1042/BCJ20210288.
2
Altered cofactor regulation with disease-associated p97/VCP mutations.疾病相关的p97/VCP突变导致辅因子调控改变。
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1705-14. doi: 10.1073/pnas.1418820112. Epub 2015 Mar 16.
3
Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.对p97/VCP ATP酶的特异性抑制及动力学分析表明D1和D2 ATP酶结构域之间存在相互作用。
J Mol Biol. 2014 Jul 29;426(15):2886-99. doi: 10.1016/j.jmb.2014.05.022. Epub 2014 May 27.
4
Adapted ATPase domain communication overcomes the cytotoxicity of p97 inhibitors.适应性 ATP 酶结构域通讯克服 p97 抑制剂的细胞毒性。
J Biol Chem. 2018 Dec 28;293(52):20169-20180. doi: 10.1074/jbc.RA118.004301. Epub 2018 Oct 31.
5
The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.N 结构域在哺乳动物 AAA ATPase p97/VCP 的 ATP 酶活性中的作用。
J Biol Chem. 2012 Mar 9;287(11):8561-70. doi: 10.1074/jbc.M111.302778. Epub 2012 Jan 23.
6
Role of the D1-D2 Linker of Human VCP/p97 in the Asymmetry and ATPase Activity of the D1-domain.人VCP/p97的D1-D2连接体在D1结构域的不对称性和ATP酶活性中的作用
Sci Rep. 2016 Jan 28;6:20037. doi: 10.1038/srep20037.
7
D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.D1环是稳定的且不依赖核苷酸,而D2环在p97-VCP的ATP酶循环过程中会发生主要的构象变化。
J Biol Chem. 2003 Aug 29;278(35):32784-93. doi: 10.1074/jbc.M303869200. Epub 2003 Jun 13.
8
AAA+ ATPase p97/VCP mutants and inhibitor binding disrupt inter-domain coupling and subsequent allosteric activation.AAA+ ATPase p97/VCP 突变体和抑制剂结合破坏结构域间的偶联和随后的别构激活。
J Biol Chem. 2021 Oct;297(4):101187. doi: 10.1016/j.jbc.2021.101187. Epub 2021 Sep 11.
9
Interaction between the AAA ATPase p97 and its cofactor ataxin3 in health and disease: Nucleotide-induced conformational changes regulate cofactor binding.AAA三磷酸腺苷酶p97与其辅助因子ataxin3在健康与疾病中的相互作用:核苷酸诱导的构象变化调节辅助因子结合。
J Biol Chem. 2017 Nov 10;292(45):18392-18407. doi: 10.1074/jbc.M117.806281. Epub 2017 Sep 22.
10
ATP binding to p97/VCP D1 domain regulates selective recruitment of adaptors to its proximal N-domain.ATP 与 p97/VCP D1 结构域结合调节衔接蛋白对其近端 N 结构域的选择性募集。
PLoS One. 2012;7(12):e50490. doi: 10.1371/journal.pone.0050490. Epub 2012 Dec 3.

引用本文的文献

1
Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitors.三唑类抑制剂对人p97/VCP ATP酶及其疾病突变体的变构抑制机制
Commun Chem. 2024 Aug 9;7(1):177. doi: 10.1038/s42004-024-01267-3.
2
Structural dynamics of AAA + ATPase Drg1 and mechanism of benzo-diazaborine inhibition.AAA+ATP 酶 Drg1 的结构动力学与苯并二氮杂硼抑制机制。
Nat Commun. 2022 Nov 9;13(1):6765. doi: 10.1038/s41467-022-34511-2.

本文引用的文献

1
Mechanistic insight into substrate processing and allosteric inhibition of human p97.解析人类 p97 的底物加工和别构抑制的机理研究
Nat Struct Mol Biol. 2021 Jul;28(7):614-625. doi: 10.1038/s41594-021-00617-2. Epub 2021 Jul 14.
2
AAA ATPases as therapeutic targets: Structure, functions, and small-molecule inhibitors.AAA 型 ATP 酶作为治疗靶点:结构、功能和小分子抑制剂。
Eur J Med Chem. 2021 Jul 5;219:113446. doi: 10.1016/j.ejmech.2021.113446. Epub 2021 Apr 10.
3
p97 and p47 function in membrane tethering in cooperation with FTCD during mitotic Golgi reassembly.
p97 和 p47 在有丝分裂期间与 FTCD 共同作用于高尔基体重装配过程中的膜连接。
EMBO J. 2021 May 3;40(9):e105853. doi: 10.15252/embj.2020105853. Epub 2021 Feb 8.
4
VCP/p97 regulates Beclin-1-dependent autophagy initiation.VCP/p97 调控 Beclin-1 依赖性自噬起始。
Nat Chem Biol. 2021 Apr;17(4):448-455. doi: 10.1038/s41589-020-00726-x. Epub 2021 Jan 28.
5
A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.一种共价 p97/VCP ATP 酶抑制剂可以克服结直肠癌细胞对 CB-5083 和 NMS-873 的耐药性。
Eur J Med Chem. 2021 Mar 5;213:113148. doi: 10.1016/j.ejmech.2020.113148. Epub 2021 Jan 2.
6
Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative.人 p97 复合物中 Npl4 的跷跷板构象和一种二硫代氨基甲酸酯衍生物的抑制机制。
Nat Commun. 2021 Jan 5;12(1):121. doi: 10.1038/s41467-020-20359-x.
7
Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction.非均匀细化:自适应正则化可改善单颗粒冷冻电镜重构。
Nat Methods. 2020 Dec;17(12):1214-1221. doi: 10.1038/s41592-020-00990-8. Epub 2020 Nov 30.
8
An intrinsically disordered motif regulates the interaction between the p47 adaptor and the p97 AAA+ ATPase.一个固有无序基序调节衔接蛋白 p47 与 p97 AAA+ATP 酶之间的相互作用。
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26226-26236. doi: 10.1073/pnas.2013920117. Epub 2020 Oct 7.
9
Allosteric p97 Inhibitors Can Overcome Resistance to ATP-Competitive p97 Inhibitors for Potential Anticancer Therapy.变构p97抑制剂可克服对ATP竞争性p97抑制剂的耐药性,用于潜在的抗癌治疗。
ChemMedChem. 2020 Apr 20;15(8):685-694. doi: 10.1002/cmdc.201900722. Epub 2020 Mar 23.
10
Multisystem Proteinopathy Mutations in VCP/p97 Increase NPLOC4·UFD1L Binding and Substrate Processing.VCP/p97 多系统蛋白病突变增加 NPLOC4·UFD1L 结合和底物加工。
Structure. 2019 Dec 3;27(12):1820-1829.e4. doi: 10.1016/j.str.2019.09.011. Epub 2019 Oct 14.